Alembic Pharma Clears Brazilian Health Regulator Audit
Alembic Pharma Ltd on Wednesday, 11 December, announced that it had successfully completed the API-II facility audit at Panelav for eight active pharmaceutical ingredients (APIs)...
Tag : Alembic Pharmaceuticals Ltd
Alembic Pharma Receives USFDA Approval for Hypertension Drug
Alembic Pharmaceutical announced on Monday, 11 November, that they had received approval from the US Food and Drug Administration (USFDA) for the Diltiazem Hydrochloride Extended-Release...
Alembic Pharma Shares Reach 52-Week High After USFDA Approval
Shares of Alembic Pharmaceuticals Ltd. rose nearly 4%, reaching a day’s high of Rs 1,303.90 on 9th October, after the company announced that the United...
Alembic Pharmaceuticals Plans 20+ US Product Launches in FY25, Shares Drop 5%
Shares of Alembic Pharmaceuticals Ltd. fell by 5% after touching a day’s high of Rs 1,225 on 9th August. The company is preparing for over...
Alembic Pharma Secures USFDA Approval for Cancer Drug; Shares Gain 3%
Shares of Alembic Pharmaceuticals Ltd were trading in the green and 3% higher on 2 August after the company announced securing final approval from the...
Alembic Pharma Gains 10% After USFDA Approval for Antipsychotic Drug
Shares of Alembic Pharmaceuticals Ltd. rose by almost 10% to touch a 52-week high of Rs 1,192.75 on 24 July after the company announced securing...
Alembic Pharma Shares Surge on USFDA Tentative Approval for Selexipag Injection
Shares of Alembic Pharmaceuticals rose by almost 2% to a day’s high of Rs 996.35 on 15 July, after the company received a tentative USFDA...
Alembic Pharma Secured USFDA Approval for Bromfenac Ophthalmic Solution
Alembic Pharmaceuticals Ltd on 9 July announced receiving approval from the US Food and Drug Administration (USFDA) for its Bromfenac ophthalmic solution that is used...
Alembic Pharmaceuticals Shares Surge 4% on Tentative USFDA Approval
Shares of Alembic Pharmaceuticals Ltd were trading 4% higher on 1 April after the company announced receiving tentative approval from USFDA. In its regulatory filing,...
Alembic Pharma Shares Slip 2% on Receiving 4 Observation from USFDA
Shares of Alembic Pharmaceuticals Ltd slumped 2% on 11 March after the USFDA issued a Form 483 with 4 observations from its Gujarat plant. In...